Transcriptional effects of (177)Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice

BACKGROUND: (177)Lu-octreotate is used for therapy of somatostatin receptor expressing neuroendocrine tumors with promising results, although complete tumor remission is rarely seen. Previous studies on nude mice bearing the human small intestine neuroendocrine tumor, GOT1, have shown that a priming...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EJNMMI Res
Main Authors: Spetz, Johan, Langen, Britta, Rudqvist, Nils-Petter, Parris, Toshima Z., Shubbar, Emman, Dalmo, Johanna, Wängberg, Bo, Nilsson, Ola, Helou, Khalil, Forssell-Aronsson, Eva
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6426909/
https://ncbi.nlm.nih.gov/pubmed/30895393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-019-0500-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados